(The Hill) The FDA placed its top two cell and gene therapy officials-- Nicole Verdun, MD, and Rachael Anatol, PhD -- on administrative leave. (Fierce Biotech) Meanwhile, the agency said it halted ...

The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a ...

AAVs play a key role in delivering gene therapies, and precise measurement of the empty/full capsid ratio—a critical quality ...

Two biotech innovators launched products that solve challenges in gene therapy scale-up and learn from omics data from animals and humans.

The HHS said center directors deserve to be supported by managers aligned with aggressive goals “to expeditiously advance ...

The reported dismissal of high-ranking CBER officials Nicole Verdun and Rachael Anatol resurfaced lingering concerns about ...

Beam Therapeutics shows promising BEACON trial results in SCD, backed by strong cash reserves and pipeline momentum. See why ...

Verve's top drug, Verve-102, is designed to target a gene called PCSK9, which is associated with heart health and cholesterol levels.

The Alliance for Regenerative Medicine has voiced deep disappointment about reports that the FDA has put the director of its ...

We look at the continued turmoil within the FDA, including the forced dismissal of top gene therapy regulator Nicole Verdun, ...

The Food and Drug Administration (FDA) announced a new crackdown Wednesday on the flow of American DNA to labs in China and other adversaries. The FDA previously […] ...

At Miami-Dade’s public hospital system Jackson Health, new advancements in genetic research recently helped doctors modify a ...